EUVIMEDEUVIMED entdecken
Crossref

Edaravone dexborneol promotes M2 microglia polarization against lipopolysaccharide-induced inflammation via suppressing TLR4/MyD88/NF-κB pathway

Jing Huang, Xiaohui Hu, Juanqin Li, Daokai Gong

Naunyn-Schmiedeberg's Archives of Pharmacology · 2024

DOI: 10.1007/s00210-024-03045-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2024. Verfasst von Jing Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, China. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Microglia, Lipopolysaccharides, Myeloid Differentiation Factor 88. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Chinese Stroke Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Edaravone dexborneol (ED) is a novel neuroprotective compound that consists of two active ingredients, edaravone and ( +)-borneol in a 4:1 ratio, which has been shown the anti-inflammatory properties in animal models of ischemic stroke, cerebral hemorrhage, and autoimmune encephalomyelitis. However, the effect of ED on the polarization of microglia in neuroinflammation has not been elucidated. This study was to investigate the effects of ED on the polarization of microglia induced by lipopolysaccharide (LPS) and potential mechanisms. BV-2 microglial cells were incubated with ED (100, 200, and 400 µM) for 2 h, followed by lipopolysaccharide (LPS, 1 µg/ml) for 12 h. The researchers used the Griess method, western blot, immunocytochemistry, and subcellular fractionation to assess the effects and potential mechanisms of ED on neuroinflammatory reactions. The expression of ROS and the activities of antioxidant enzymes (SOD, GPx, and CAT) in LPS-induced BV-2 cells were also measured using the DCFH-DA fluorescent probe and colorimetric methods, respectively. It was observed that ED significantly declined the levels of TLR4/NF-κB pathway-associated proteins (TLR4, MyD88, p65, p-p65, IκBα, p-IκBα, IKKβ, p-IKKβ) and therefore inhibited LPS-induced production of NO, IL-1β, and TNF-α. Moreover, ED markedly downregulated the M1 marker (iNOS) and upregulated the M2 marker (Arginase-1, Ym-1). In addition, ED also reduced ROS generation and enhanced GPx activity. ED induced the polarization of LPS-stimulated microglia from M1 to M2 against inflammation by negatively regulating the TLR4/MyD88/NF-κB signaling pathway. Additionally, ED performed antioxidative function by depleting the intracellular excessive ROS caused by LPS through the enhancement of the enzymatic activity of GPx. ED may be a potential agent to attenuate neuroinflammation via regulating the polarization of microglia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 4MicrogliaLipopolysaccharidesMyeloid Differentiation Factor 88NF-kappa BSignal TransductionEdaravoneAnimalsMiceCell LineReactive Oxygen SpeciesAnti-Inflammatory AgentsInflammationNeuroprotective Agents

Stichwörter der Autor:innen

BV-2 microgliaEdaravone dexborneolLipopolysaccharidePolarizationTLR4/MyD88/NF-κB pathway

Substanzen

Toll-Like Receptor 4LipopolysaccharidesMyeloid Differentiation Factor 88NF-kappa BEdaravoneTlr4 protein, mouseReactive Oxygen SpeciesAnti-Inflammatory AgentsMyd88 protein, mouseNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Neurology, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, China.
  • Department of Neurology, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, China. dk_gong@163.com.

Förderung

  • Chinese Stroke Association

Zitieren

APA

Huang, J., Hu, X., Li, J., & Gong, D. (2024). Edaravone dexborneol promotes M2 microglia polarization against lipopolysaccharide-induced inflammation via suppressing TLR4/MyD88/NF-κB pathway. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03045-3

Vancouver

Huang J, Hu X, Li J, Gong D. Edaravone dexborneol promotes M2 microglia polarization against lipopolysaccharide-induced inflammation via suppressing TLR4/MyD88/NF-κB pathway. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024. doi:10.1007/s00210-024-03045-3

BibTeX
@article{Huang2024,
  author = {Huang, Jing and Hu, Xiaohui and Li, Juanqin and Gong, Daokai},
  title = {Edaravone dexborneol promotes M2 microglia polarization against lipopolysaccharide-induced inflammation via suppressing TLR4/MyD88/NF-κB pathway},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2024},
  doi = {10.1007/s00210-024-03045-3}
}
Kostenlos starten →